Rethinking Mood Treatments
35:12–35:52 · 40s
While SSRIs remain standard for PMDD, Rubin argues immune pathways may be driving symptoms for some women, raising the case to explore antihistamine combinations and new therapies.
35:12–35:52 · 40s
While SSRIs remain standard for PMDD, Rubin argues immune pathways may be driving symptoms for some women, raising the case to explore antihistamine combinations and new therapies.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.